Literature DB >> 25817932

Best practice for diabetic patients on hemodialysis 2012.

Toshiyuki Nakao1, Masaaki Inaba, Masanori Abe, Kazo Kaizu, Kenji Shima, Tetsuya Babazono, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25817932     DOI： 10.1111/1744-9987.12299

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN： 1744-9979            Impact factor:   1.762


× No keyword cloud information.
  16 in total

1.  Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.

Authors:  Sayo Ueda; Kojiro Nagai; Narushi Yokota; Daisuke Hirose; Hiroaki Mori; Yoshihiko Noma; Toshio Doi; Jun Minakuchi
Journal:  J Artif Organs       Date:  2019-02-25       Impact factor: 1.731

2.  Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study.

Authors:  Naoshi Yoshida; Tetsuya Babazono; Ko Hanai; Yasuko Uchigata
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

Review 3.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

4.  A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal.

Authors:  Long Su; Guannan Huang; Songtao Yin; Xia Hua; Xin Tang
Journal:  BMC Ophthalmol       Date:  2018-02-08       Impact factor: 2.209

5.  Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Authors:  Ayumi Nakatani; Shinya Nakatani; Eiji Ishimura; Takayo Murase; Takashi Nakamura; Mari Sakura; Yu Tateishi; Akihiro Tsuda; Masafumi Kurajoh; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

6.  Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients.

Authors:  Shinya Nakatani; Keiko Yasukawa; Eiji Ishimura; Ayumi Nakatani; Norikazu Toi; Hideki Uedono; Akihiro Tsuda; Shinsuke Yamada; Hitoshi Ikeda; Katsuhito Mori; Masanori Emoto; Yutaka Yatomi; Masaaki Inaba
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

7.  Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation.

Authors:  Lucrezia Ferrario; Fabrizio Schettini; Angelo Avogaro; Chiara Bellia; Federico Bertuzzi; Graziella Bonetti; Antonio Ceriello; Marcello Ciaccio; Massimiliano Corsi Romanelli; Elena Dozio; Luca Falqui; Angela Girelli; Antonio Nicolucci; Gianluca Perseghin; Mario Plebani; Umberto Valentini; Martina Zaninotto; Silvana Castaldi; Emanuela Foglia
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-27

8.  Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.

Authors:  Hiroki Kobayashi; Masanori Abe; Yoshinori Yoshida; Hiroko Suzuki; Noriaki Maruyama; Kazuyoshi Okada
Journal:  Int J Mol Sci       Date:  2016-04-25       Impact factor: 5.923

9.  Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.

Authors:  Masakazu Haneda; Takashi Kadowaki; Hiroshi Ito; Kazuyo Sasaki; Sonoe Hiraide; Manabu Ishii; Miyuki Matsukawa; Makoto Ueno
Journal:  Diabetes Ther       Date:  2018-04-10       Impact factor: 2.945

10.  Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin.

Authors:  Takumi Minezumi; Shin-Ichi Takeda; Yusuke Igarashi; Kentaro Sato; Yoshiaki Murakami; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.